Evidence map›Paper›PMID 22451944›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages.

Kate Schroder, Katharine M Irvine, Martin S Taylor, Nilesh J Bokil, Kim-Anh Le Cao, Kelly-Anne Masterman, Larisa I Labzin, Colin A Semple, Ronan Kapetanovic, Lynsey Fairbairn and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 5 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 5 syntheses or guidelines pooled it, 311 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Meta-Analysis ofFrontiers in immunology · 2019
    Pooled it
  5. Pooled it
  6. Transcriptional regulation and function of GPR18 in macrophage subtype specification.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Systems analysis reveals alternate metabolic states adopted bybioRxiv : the preprint server for biology · 2025
    Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 4 countries.

Kate SchroderInstitute for Molecular Bioscience, University of Queensland, Brisbane 4072, Australia. k.schroder@imb.uq.edu.au
Katharine M Irvine
Martin S Taylor
Nilesh J Bokil
Kim-Anh Le Cao
Kelly-Anne Masterman
Larisa I Labzin
Colin A Semple
Ronan Kapetanovic
Lynsey Fairbairn
Altuna Akalin
Geoffrey J Faulkner
John Kenneth Baillie
Milena Gongora
Carsten O Daub
Hideya Kawaji
Geoffrey J McLachlan
Nick Goldman
Sean M Grimmond
Piero Carninci
Harukazu Suzuki
Yoshihide Hayashizaki
Boris Lenhard
David A Hume
Matthew J Sweet
University of Queensland · AURIKEN Center for Integrative Medical Sciences · JPRoslin Institute · GBUniversity of Edinburgh · GBCornell University · USImperial College London · GBMRC Human Genetics UnitWellcome Trust · GBWestern General Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I024801/1Biotechnology and Biological Sciences Research Council BBS/E/D/20251969Medical Research Council MC_PC_U127597124Medical Research Council MC_U127597124
6 · The paper itself

Abstract

Evolutionary change in gene expression is generally considered to be a major driver of phenotypic differences between species. We investigated innate immune diversification by analyzing interspecies differences in the transcriptional responses of primary human and mouse macrophages to the Toll-like receptor (TLR)-4 agonist lipopolysaccharide (LPS). By using a custom platform permitting cross-species interrogation coupled with deep sequencing of mRNA 5' ends, we identified extensive divergence in LPS-regulated orthologous gene expression between humans and mice (24% of orthologues were identified as "divergently regulated"). We further demonstrate concordant regulation of human-specific LPS target genes in primary pig macrophages. Divergently regulated orthologues were enriched for genes encoding cellular "inputs" such as cell surface receptors (e.g., TLR6, IL-7Rα) and functional "outputs" such as inflammatory cytokines/chemokines (e.g., CCL20, CXCL13). Conversely, intracellular signaling components linking inputs to outputs were typically concordantly regulated. Functional consequences of divergent gene regulation were confirmed by showing LPS pretreatment boosts subsequent TLR6 responses in mouse but not human macrophages, in keeping with mouse-specific TLR6 induction. Divergently regulated genes were associated with a large dynamic range of gene expression, and specific promoter architectural features (TATA box enrichment, CpG island depletion). Surprisingly, regulatory divergence was also associated with enhanced interspecies promoter conservation. Thus, the genes controlled by complex, highly conserved promoters that facilitate dynamic regulation are also the most susceptible to evolutionary change.

Indexed as

Gene Expression ProfilingGenetic VariationAnimalsCell LineCells, CulturedChemokine CCL20Chemokine CXCL13Evolution, MolecularFemaleGene Expression RegulationHost-Pathogen InteractionsHumansLipopolysaccharidesMacrophagesMaleMiceChemokine CCL20Chemokine CXCL13LipopolysaccharidesToll-Like Receptor 4

Identifiers

PMID22451944
PMCPMC3341041
OpenAlexW1997423398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.